Commentary: Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone

Xiang-Dong Wu¹, Ke-Jia Hu^{2

3}, Wei Huang¹

Affiliations

¹ Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
² Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
³ Department of Microsurgery, Huashan Hospital, Fudan University, Shanghai, China.

Comment

Xiang-Dong Wu et al. Front Aging Neurosci. 2017.

. 2017 Nov 7:9:357.

doi: 10.3389/fnagi.2017.00357. eCollection 2017.

Xiang-Dong Wu¹, Ke-Jia Hu^{2

3}, Wei Huang¹

¹ Department of Orthopaedic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
² Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
³ Department of Microsurgery, Huashan Hospital, Fudan University, Shanghai, China.

No abstract available

Keywords: atrial fibrillation; bisphosphonates; cardiovascular comorbidities; hip fracture; prednisolone.

Comment on

Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone.
Axelsson KF, Nilsson AG, Wedel H, Lundh D, Lorentzon M. Axelsson KF, et al. JAMA. 2017 Jul 11;318(2):146-155. doi: 10.1001/jama.2017.8040. JAMA. 2017. PMID: 28697254 Free PMC article.

1. Axelsson K. F., Nilsson A. G., Wedel H., Lundh D., Lorentzon M. (2017). Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone. JAMA 318, 146–155. 10.1001/jama.2017.8040 - DOI - PMC - PubMed
1. Black D. M., Delmas P. D., Eastell R., Reid I. R., Boonen S., Cauley J. A., et al. (2007). Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N. Engl. J. Med. 356, 1809–1822. 10.1056/NEJMoa067312 - DOI - PubMed
1. Emdin C. A., Wong C. X., Hsiao A. J., Altman D. G., Peters S. A., Woodward M., et al. (2016). Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies. BMJ 532:h7013. 10.1136/bmj.h7013 - DOI - PMC - PubMed
1. Sharma A., Chatterjee S., Arbab-Zadeh A., Goyal S., Lichstein E., Ghosh J., et al. (2013). Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis. Chest 144, 1311–1322. 10.1378/chest.13-0675 - DOI - PubMed
1. Wang J. C., Chien W. C., Chung C. H., Liao W. I., Tsai S. H. (2016). Adverse cardiovascular effects of nitrogen-containing bisphosphonates in patients with osteoporosis: a nationwide population-based retrospective study. Int. J. Cardiol. 215, 232–237. 10.1016/j.ijcard.2016.04.088 - DOI - PubMed